October 11-12, 2017: Meeting Materials FDA Generated
Final Agenda: Oct. 11-12, 2017
FDA Discussion Questions: Oct. 11-12, 2017
Roster: Oct. 11-12, 2017
Roundtable Scenarios and Questions: Oct. 11-12, 2017
Webcast Information: Oct. 11-12, 2017
FDA Executive Summary : Oct. 11-12, 2017
Bibliography: Oct. 11-12, 2017
Clinical Trials and Medical Device, FDA, Owen Faris, Ph.D.
Partnering with Patients, FDA, Kathryn O'Callaghan
PEAC Meeting, Day 1 Summary, FDA, Dr. Michelle Tarver
PEAC 24hr Summary
Clinical Trail Glossary Terms
Transcript: Oct. 11, 2017
Transcript: Oct. 12, 2017
October 11-12, 2017: Meeting Materials Non-FDA Generated
Industry Practices that Benefit/Will Benefit by Patient Engagement, Tufts, Ken Getz
Patient Engagement Efforts with the Clinical Trial Enterprise , Bray Patrick-Lake, Duke
Patient Involvement in the Design of Clinical Trials, AstraZeneca, Faye O'Brien,
Advocate Engagement and Clinical Trials, NCI
SCRIPPS, VitalCrowd, Anna McCollister-Slipp
Patient Centered Designs Case Study, Johnson
Patient Recruitment, Enrollment, and Retention, Boston Scientific, Dr. Kenneth Stein
Patient and Public Driven Research, PCORI, Kristin Carman
Patient Recruitment, Enrollment, and Retention, NORD, Paul Melmeyer
Considerations in Reporting Results of Clinical Trials,NLOM, Dr. Deborah Zarin
The mPower Study,Sage BIONETWORKS, John Wilbanks
Content current as of:
11/08/2017
Back to Top